Parallax Volatility Advisers, L.P. - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 191 filers reported holding REVANCE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.

Quarter-by-quarter ownership
Parallax Volatility Advisers, L.P. ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$114,700
-89.9%
10,000
-77.8%
0.00%
-100.0%
Q2 2023$1,141,101
-15.9%
45,085
+7.0%
0.00%0.0%
Q1 2023$1,357,555
-15.8%
42,147
-29.4%
0.00%
+50.0%
Q3 2022$1,612,000
+323.1%
59,700
+116.3%
0.00%
Q2 2022$381,000
+5.2%
27,600
+53.3%
0.00%
Q4 2018$362,000
-19.0%
18,0000.0%0.00%
-100.0%
Q3 2018$447,000
-9.5%
18,0000.0%0.00%0.0%
Q2 2018$494,000
+298.4%
18,000
+345.5%
0.00%
Q1 2018$124,000
-95.5%
4,040
-94.8%
0.00%
-100.0%
Q4 2017$2,767,00077,3940.00%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Essex Woodlands Management, Inc. 3,342,047$94,714,00024.58%
Palo Alto Investors LP 2,673,313$75,762,0003.97%
Evolutionary Tree Capital Management, LLC 89,348$2,532,0001.93%
RICE HALL JAMES & ASSOCIATES, LLC 1,121,152$31,773,0001.12%
ArrowMark Colorado Holdings LLC 2,964,135$84,004,0000.65%
Rhenman & Partners Asset Management AB 220,000$6,235,0000.51%
Fosun International Ltd 233,841$6,627,0000.43%
OSTERWEIS CAPITAL MANAGEMENT INC 174,970$4,959,0000.30%
ESSEX INVESTMENT MANAGEMENT CO LLC 76,671$2,173,0000.27%
Tekla Capital Management LLC 213,808$6,059,0000.21%
View complete list of REVANCE THERAPEUTICS INC shareholders